Strategy
Portfolio
People
Careers
News
Blog
Contact Us

August 13, 2018

FDA approves Ivantis’ Hydrus microstent

Back Portfolio News Next

Back Blog Next

©2022 Foresite Capital Management, LLC. Site by GOODLAB

Strategy
Portfolio
People
Careers
News
Blog
Contact Us

Contact Us
Foresite Labs
Investor Login
Terms
Privacy Policy

News
Blog
Foresite Labs
Contact Us

Home
Strategy
Portfolio
People
Careers
News
Blog
Contact Us
Foresite Labs
Investor Login
Terms
Privacy Policy

Blog
Careers
Contact Us
Disclosures
Home
Legal Disclaimers
Pardes Biosciences Legend
Privacy Policy
Strategy
Terms

©2024 Foresite Capital Management, LLC.

Site by Goodlab